In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease. - Yassir Boulaamane; Mahmoud A. A. Ibrahim; Mohammed-Reda Britel; Amal A. M. Maurady (J. Integr. Bioinform., 2022)

Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations. - Yassir Boulaamane; Santiago Bolivar Avila; Juan Rosales Hurtado; Iman Touati; Badr-Edine Sadoq; Aamal A. Al-Mutairi; Ali Irfan; Sami A. Al-Hussain; Amal A. M. Maurady; Magdi E. A. Zaki (Comput. Biol. Medicine, 2025)